<<

Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Cancer Epidemiology, Research Article Biomarkers & Prevention

Psychological Distress after a Positive Fecal Occult Blood Test Result among Members of an Integrated Healthcare Delivery System

Sharon S. Laing1,4, Andy Bogart3, Jessica Chubak2,3, Sharon Fuller3, and Beverly B. Green3

Abstract Background: Colorectal cancer screening (CRCS) reduces morbidity and mortality; however, the positive benefits might be partially offset by long-term distress following positive screening results. We examined relationships among colorectal cancer–specific worry and situational anxiety after positive fecal occult blood tests [FOBT (þ)] compared with receipt of negative results. Methods: Of note, 2,260 eligible members of Group Health, an integrated healthcare delivery system, completed baseline surveys and received FOBT screening kits, with 1,467 members returning the kits. We matched FOBT (þ) patients (n ¼ 55) 1:2 on age and sex with FOBT () respondents (n ¼ 110). Both groups completed follow-up surveys at 7 to 14 days and 4 months after screening. We assessed situational anxiety (State-Trait Anxiety Inventory, STAI), colorectal cancer worry frequency, and mood disturbance. Results: Mean age was 59 years, and majority were women (62%) and White (89%). After adjusting for age, sex, and baseline worry, at 7 to 14 days after screening, the FOBT (þ) group was 3.82 [95% confidence interval (CI), 1.09–13.43] times more likely to report colorectal cancer–related mood disturbances and significantly higher mean STAI scores than the FOBT () group (mean ¼ 38.8 vs. 30.9; P ¼ 0.007). At 4-month posttest, mood disturbances and situational anxiety seemed to drop to baseline levels for FOBT (þ). No colon cancer worry frequency was observed. Conclusions: FOBT (þ) results are associated with short-term situational anxiety and colorectal cancer– specific mood disturbances. Impact: Distress from FOBT (þ) results declined to near-baseline levels by 4 months. Additional studies are needed to clarify the relationship between long-term distress and follow-up colonoscopy. Cancer Epidemiol Biomarkers Prev; 23(1); 154–9. 2013 AACR.

Introduction The relationship between receipt of a positive FOBT Colorectal cancer screening (CRCS) reduces morbidity screen result and associated negative psychological con- and mortality; however, little is known about the - sequences is less well studied; the few available studies logical consequences of receiving a positive fecal occult have reported heightened distress immediately following a blood test [FOBT (þ)] screening result. Distress after a positive outcome with no evidence of sustained distress positive screen is evident for cervical, prostate, and breast beyond4 months posttest (7–9). Onlyone study (8) assessed cancers, with anxiety lasting for short-time periods psychological status both before and after receiving screen- including 2 weeks posttest (1–5) and longer periods ing, and none assessed the relationship between CRCS including several months (2, 6). For breast cancer, the result and colon cancer–specific worry (7, 8). It is important deleterious effects include heightened anxiety and worry to understand the implications of participating in a colon (6). cancer–screening program and the experience of adverse psychological events (10–13). The objective of this study is to evaluate the relationship between receiving a positive

Authors' Affiliations: 1Health Promotion Research Center, University of FOBT screen result and patients’ experience of short- and Washington; 2Department of Epidemiology, University of Washington; longer-term cancer-specific worry and situational anxiety. 3Group Health Research Institute, Seattle; and 4Department of Psychology, Eastern Washington University, Bellevue, Washington Materials and Methods Corresponding Author: Sharon S. Laing, Department of Psychology, Eastern Washington University, 3000 Landerholm Circle, SE, Bellevue, WA Participants of this longitudinal study were members of 98007. Phone: 425-564-5100; Fax: 425-564-5110; E-mail: Group Health, an integrated health insurance and care [email protected] delivery system in Washington State. The Group Health doi: 10.1158/1055-9965.EPI-13-0722 Institutional Review Board approved all study documents 2013 American Association for Cancer Research. and procedures.

154 Cancer Epidemiol Biomarkers Prev; 23(1) January 2014

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Psychological Distress and FOBT

Recruitment occurred between January and February Measures 2011. Members were 50 to 74 years of age, continuously Demographic characteristics and relevant background enrolled in Group Health for at least 2 years, received care information (from baseline surveys) included health his- at one of 21 Group Health Medical Centers in Western tory and previous colorectal cancer diagnosis; CRCS Washington, and due for CRCS based on administrative behaviors and future intention to be screened; colorectal and clinical data. Eligibility criteria based on CRCS were cancer knowledge, confidence about screening, and per- as follows: no evidence of an FOBT in the last 8 months, no ceived barriers to screening; and colorectal cancer worry flexible sigmoidoscopy in the last 4 years, and no colo- frequency and situational anxiety. noscopy in the last 9 years. We also used clinical data to exclude prospective participants based on the following Colon cancer–specific worry factors: (i) history of colorectal cancer, inflammatory bow- We assessed colorectal cancer–specific worry at baseline el disease, or total colectomy; (ii) a myocardial infarction (T1), 7 to 14 days after the FOBT screen result (T2), and 4 in the previous 12 months; (iii) end-stage or organ failure months after FOBT screen result (T3) by asking two ques- diseases; and (iv) active treatment for cancer with tions. The first question asked about worry frequency— chemotherapy. "How often do you worry about getting colon cancer?" We mailed an invitation letter, baseline surveys, and a and the item was rated on a 5-point Likert scale, ranging $2 incentive to 9,922 Group Health patients. Participants from "never" (1) to "all the time" (5). We designated who returned baseline questionnaires and provided respondents as "no worry" by combining the following informed consent were further checked for eligibility results (never ¼ 1 and rarely ¼ 2) and "yes, at least some based on their response to the survey. Patients who worry" by combining the following results (sometimes ¼ reported prior colorectal cancer and a first-degree relative 3, most of the time ¼ 4, and all of the time ¼ 5). Similar diagnosed with colorectal cancer at age 60 or younger studies have used this single-item scale to assess worry were excluded, as were those who self-reported having a frequency related to a cancer diagnosis (14). colonoscopy in the last 9 years. Prospective respondents The second question assessed the effect of recent colo- who were eligible after the baseline surveys were ran- rectal cancer worry on mood—"During the past two weeks, domly assigned to receive one of three types of mailed how often have thoughts about getting colorectal cancer FOBT kits (1-sample OC-Auto fecal immunochemical test affected your mood?" The question was rated on a 5-point (FIT); 2-sample InSure FIT; 3-sample guaiac Hemoccult Likert scale, from "never" (1) to "all the time" (5). We SENSA), in addition to instructions and postage paid designated respondents as "no impact on mood" by com- return envelope. bining the following results (not at all ¼ 1 and rarely ¼ 2) Participants returning the FOBT kits and with FOBT- and "yes, at least some impact on mood" by combining the positive results were matched by age and sex to two following results (sometimes ¼ 3, most of the time ¼ 4, and FOBT-negative participants and mailed a second wave all of the time ¼ 5). of questionnaires within two business days of the FOBT screen result (7–14 days posttest; Fig. 1). Nonresponders Situational anxiety received telephone reminders to complete questionnaires We assessed situational anxiety at all three time points and we excluded individuals who completed question- using the 40-item State component of the State-Trait Anx- naires more than 21 days after FOBT screen result because iety Inventory (STAI). This measure captures symptoms of our interest in measuring short-term distress related to of anxiety that the respondent experienced at a single screening. Group Health Cooperative provides patients moment in time, and is rated on a 4-point scale with a score with FOBT-positive outcome, a copy of their laboratory range of 20 to 80, with higher scores indicating more results with a mailed standard letter that explains the anxiety (15). result. Patients are also asked to contact their physician’s office by phone if they have not already been contacted. We mailed out the third wave of questionnaires (T3) to Statistical Analyses the FOBT-positive patients and their matched controls at 4 We calculated frequency distributions for categorical months after receipt of the screening test result. All parti- variables (frequency of cancer worry and effect of recent cipants received the T3 follow-up surveys even if they did cancer worry on mood) for which binary categories not return T2 follow-up surveys. Similar to T2, we of "yes" and "no" were created, and then calculated means prompted T3 survey nonresponders by providing tele- and SDs for continuous variables (State component of phone reminders and allowed 2 months for returning the STAI). c2 analyses were used to assess differences among surveys before excluding the participant. Participants categorical variables and t tests were implemented to received $20.00 after completion of the T2 and T3 surveys. compare age in years, allowing unequal variances. Participants who were excluded due to length of time We analyzed binary outcomes at baseline with log- past randomization (n ¼ 9) or lack of completion of the linear regression models that accommodated clustering follow-up surveys (n ¼ 15) did not differ significantly on within matched positives and negatives. Continuous vari- any baseline characteristics compared with those who ables at baseline were modeled with linear regression remained in the analyses. models, which similarly accommodated clustering within

www.aacrjournals.org Cancer Epidemiol Biomarkers Prev; 23(1) January 2014 155

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Laing et al.

Excluded from analysis upon delayed detection of Sent FOBT kit as part of larger study prerandomization exclusionary events 2,260 Not enrolled at randomization 10 Prerandomization colonoscopy 9 Prerandomization flexible sigmoidoscopy 3 Self-reported complete FOBT 1 Self-reported up-to-date other screening 2 Requested termination 1 Total 26

At least one FOBT before end of matching period No FOBT before end of matching period 1,467 767

Negative results At least one positive Indeterminate result, matched on age results 1,338 group and sex to two 73 Not matched similar negatives 1,028 55 Matched to 55 Figure 1. Recruitment of study positives participants for psychological FOBT result occurred = FOBT result occurred = 180 days past 110 180 days past distress and FOBT study. randomization randomization 4 5

Follow-up among matched negatives Follow-up among matched positives Completed T3 Completed T3 survey within survey within 180 days of 180 days of FOBT result FOBT result Yes No Yes No Completed T2 Yes 72 10 82 Completed T2 Yes 27 7 34 survey within survey within 21 days of 21 days of FOBT result No 14 9 23 FOBT result No 11 6 17 86 19 105 38 13 51

Excluded for lack of Analytic sample Excluded for lack of Analytic sample follow-up data 45 follow-up data 96 9 6

matched sets. Although FOBT-positive and -negative 2,260 eligible respondents and 1,467 FOBT kits were subjects were matched on age and sex, we found that returned—a 64.9% participation rate. We matched 55 dropout during follow-up was not uniform across the FOBT (þ) respondents with 110 FOBT () respondents. matched sets, rendering adjustment only through match- We excluded 4 FOBT (þ) and 5 FOBT () individuals ing inadequate to control for potential confounding. because their screen test results occurred later than 180 Therefore, all regression models were adjusted for age in days past randomization. We further excluded 6 FOBT (þ) years and sex. To evaluate differences at T2 and T3, we and 9 FOBT () subjects who did not complete at least one fitted longitudinal mixed-effects regression models that of the two follow-up surveys. Our final sample consisted controlled for the baseline value of the outcome and of 45 FOBT (þ) and 96 FOBT () respondents. modeled random intercepts for each subject to accommo- date correlations among survey responses by the Study sample characteristics individual. Table 1 presents the demographic and background characteristics of the study population. The mean age of Results study participants was 59 years. The majority were wom- Recruitment en (62%), White (89%), and married or living with a Figure 1 shows the study recruitment process. We partner (69%). FOBT () patients were more likely to be distributed FOBT kits and background questionnaires to White (92% vs. 84%), slightly more likely than FOBT (þ)to

156 Cancer Epidemiol Biomarkers Prev; 23(1) January 2014 Cancer Epidemiology, Biomarkers & Prevention

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Psychological Distress and FOBT

Table 1. Demographic and background FOBT ( ) groups at baseline, 7 to 14 days, and 4 months after the FOBT screen result. characteristics of study sample at baseline Colon cancer–specific worry: worry frequency (1-item worry frequency measure). Afteradjustingforbaseline Demographic and status, age, and sex, the FOBT (þ)groupwas2.03 background FOBT (þ), FOBT (), [95% confidence interval (CI), 0.92–4.50) times more N ¼ N ¼ P characteristics 45% 96% likely than the FOBT () group to report frequent colon Age, y cancer worry at 7 to 14 days after FOBT result and 1.76 50–64 87 81 (95% CI, 0.81–3.83) times more likely than FOBT ()to 65þ 13 19 0.43 report frequent colon cancer worry at 4 months; both Mean age 59.8 58.6 results were not significant. Gender Colon cancer–specific worry: mood disturbance (1-item Female 67 60 recent colorectal cancer worry measure). The FOBT (þ) Male 33 40 0.48 group was 3.82 (95% CI, 1.09–13.43) times more likely Race than the FOBT () group to report mood disturbance White 84 92 associated with recent colorectal cancer worry at 7 to 14 African American/Black 7 0 days posttest. For the FOBT (þ) group, mood distur- Asian Pacific Islander 2 6 bance increased almost 5-fold from baseline to 7 to 14 American Indian/Native 01 days posttest (4.4% to 20.6%), then decreased to near- American baseline levels by 4 months posttest. The disparity in Multiple races endorsed 5 0 mood disturbance between FOBT (þ)andFOBT()was Other 2 1 0.04 greater at 4 months posttest than at baseline (baseline ¼ Marital status 4.4 vs. 4.2, and 4 months posttest ¼ 5.7 versus 2.4, Married or living with 67 69 respectively), the result due to lowered mood distur- partner bance among FOBT () at 4 months posttest compared Not married or living 33 31 0.83 with baseline. with a partner Situational anxiety (STAI). After adjusting for baseline Education status, age, and sex, the FOBT (þ) group reported signif- High school grad/GED 18 16 icantly higher situational anxiety than the FOBT () group Some college, no degree 47 37 at T2 (mean STAI score ¼ 38.8 vs. 30.9, respectively), but Bachelor's degree or 36 47 0.44 not at 4 months. Although FOBT (þ) persons reported higher higher situational anxiety, the mean level of experienced Employment status anxiety was not clinically meaningful (STAI 54 for Full-time or part-time 56 69 clinical status) at any of the three time points. Retired 33 22 Follow-up colonoscopy. A total of 41 of the 45 (91.1%) Other 11 9 0.29 FOBT (þ) patients received follow-up colonoscopy within Family history of colorectal cancer 12 months of the receipt of their positive result. Of these, Yes 9 2 34 returned T3 surveys. Among the 34 who returned T3 No 78 95 surveys, 30 patients received a follow-up colonoscopy Do not know 13 3 0.13 before returning T3 surveys, and 4 received a follow-up NOTE: P values are from c2 tests of homogeneity for cate- colonoscopy after returning T3 surveys. The mean STAI t score for patients with a follow-up colonoscopy before gorical variables, and from test for age in years, accom- ¼ modating unequal variances. completing T3 surveys was 32.93 (SD 11.16) and mean STAI score for patients with a follow-up colonoscopy after Participants who did not respond are as follows: race, 2 ¼ FOBT (þ) and 8 FOBT () participants; marital status, 2 FOBT completing T3 surveys was 41.75 (SD 24.66). Two (6.6%) of the 30 FOBT (þ) patients who received colonoscopy (þ) and 8 FOBT () participants; education, 2 FOBT () before returning T3 surveys reported recent cancer worry participants; employment status, 2 FOBT ( ) participants; þ family history, 1 FOBT () group participant. and 1 (25%) of the 4 FOBT ( ) patients who received colonoscopy after returning T3 surveys reported recent cancer worry. All 4 patients who did not complete follow- up colonoscopies returned T3 surveys. The data suggest have a bachelor’s degree or higher (47% vs. 36%), and to be elevated colon cancer–specific worry and situational anx- employed full or part time (69% vs. 56%), but none of these iety among the FOBT (þ) patients who did not have a differences were significant. colonoscopy before completing T3 surveys versus FOBT (þ) patients who already had the colonoscopy at the time Psychological characteristics for FOBT screening test of T3 surveys. However, because of insufficient sample Table 2 presents results for colon cancer worry, mood size, we did not conduct formal statistical testing of the disturbance, and situational anxiety for the FOBT (þ) and differences observed.

www.aacrjournals.org Cancer Epidemiol Biomarkers Prev; 23(1) January 2014 157

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Laing et al.

Discussion In this study, patients receiving an FOBT (þ) result experienced significantly elevated short-term mood dis- 4.98) (95% CI) – 3.83) 26.75)

b turbances and situational anxiety compared with patients – –

1.56 who received a negative screen result. By 4 months post- test, situational anxiety decreased toward baseline levels.

difference since baseline Although cancer-specific mood disturbance also subsided ) group. Adjusted RR (95% CI) Adjusted change 1.76 (0.81 5.07 (0.96 1.71 (

to baseline levels among FOBT (þ) patients, the differ- ences seemed larger between FOBT (þ) and FOBT ()at4 ) ) months, and this is attributed to a lowering of mood disturbance among FOBT () respondents. 86% ¼ mean The findings demonstrating a short-term negative psy- FOBT ( N 18.6 FOBT ( 2.4 30.6 4 months post FOBT chological impact of receiving a positive FOBT result are consistent with several other studies showing short-term )

) psychological distress associated with positive screen test þ þ outcome (7, 8). In comparison with these analyses, we 38% included measures of colon cancer–specific distress, thus ¼ mean N FOBT ( 29.0 5.7 34.6 FOBT ( providing a targeted assessment. The targeted approach may have enabled us to detect the substantial short-term impact of a positive screen test outcome, as evidenced by ) group minus the change in the FOBT ( FOBT (þ) patients reporting more elevated colon cancer– a a related mood disturbance relative to situational anxiety at

(95% CI) 7 to 14 days after screen result. 4.50) 13.43) 7.95) b – – – Although short-term mood disturbances and situation- al anxiety were pronounced at 7 days posttest, the asso-

difference since baseline ciation disappeared as emotional responses declined Adjusted RR (95% CI) 2.03 (0.92 Adjusted change 3.82 (1.09 4.59 (1.23 toward baseline values by 4 months posttest. Although

) groups over time the numbers were too small to infer statistical significance, it is potentially noteworthy that 30 of 34 FOBT (þ) patients ) ) who had a follow-up colonoscopy before completing T3 82% on average reported lower colon cancer worry and ¼ mean 14 days post FOBT – FOBT ( N 15.9 FOBT ( 4.9 30.9 situational anxiety compared with respondents com- 7 pleting the colonoscopy after the survey. Further study

) and FOBT ( of the psychological consequences of receiving a posi- þ ) ) þ

þ tive FOBT screen result without follow-up assessment is

34% warranted. ¼ mean Factors shown to reduce the experience of psychologi- 35.3 FOBT ( N 20.6 FOBT ( 38.8 cal distress in stressful situations (e.g., receipt of a positive screen result) are patients’ perception of risk and subse- ) ) quent appraisal of the potentially stressful event. Risk

96% appraisal research has shown that an event that one ¼ mean perceives as personally impactful (stressful) will lead to 14.6 FOBT ( N 4.2 FOBT ( 32.5 elevated situational anxiety (16, 17); however, perceived control over the stressful event contributes to the devel- ) )

Baseline opment and implementation of favorable coping strate- þ þ gies that might minimize the distress (18, 19, 20, 21, 22). 45% þ ¼

mean The above might be relevant to the subset of FOBT ( ) 17.8 4.4 FOBT ( N 35.6 patients.

Study limitations The limitations of the study include the small numbers

cant differences. of positive FOBT results and missing psychological status fi data for 7 patients of the 41 who completed follow-up Results for psychological outcomes for FOBT ( colonoscopies. In spite of these limitations, we compared longitudinally the psychological status of FOBT (þ) and FOBT () respondents, and obtained important prelimi- frequency disturbance (STAI) For continuous outcomes, differences shown are age- and gender-adjusted estimates of the change in FOBT ( þ Indicates signi Colon cancer worry Colon cancer mood Table 2. a b Binary outcomes Continuous outcomes FOBT ( NOTE: To evaluate differences at T2 and T3, longitudinalfor mixed-effects regression age models were in used that years controlled for and baselineAbbreviation: outcome gender. values. RR, All regression relative models were risk. adjusted Situational anxiety nary data of the psychological status of patients before and after follow-up colonoscopy.

158 Cancer Epidemiol Biomarkers Prev; 23(1) January 2014 Cancer Epidemiology, Biomarkers & Prevention

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Psychological Distress and FOBT

Summary Authors' Contributions Conception and design: S.S. Laing, B. Green Our study is possibly the first in the United States to Development of methodology: B. Green assess colon cancer–specific psychological harms associ- Acquisition of data (provided animals, acquired and managed patients, provided facilities, etc.): S.S. Laing, B. Green ated with receiving a positive FOBT screening result. The Analysis and interpretation of data (e.g., statistical analysis, biostatis- targeted assessment and repeated measures enabled the tics, computational analysis): S.S. Laing, A. Bogart, J. Chubak, B. Green detection of a robust short-term negative psychological Writing, review, and/or revision of the manuscript: S.S. Laing, A. Bogart, J. Chubak, S. Fuller, B. Green impact. Administrative, technical, or material support (i.e., reporting or orga- The observed colon cancer–specific mood disturbance nizing data, constructing databases): S. Fuller, B. Green and situational anxiety seemed to decline by 4 months after Study supervision: S.S. Laing, B. Green screening for FOBT (þ) patients; however, we cannot rule out persistent psychological distress among those who do Grant Support not receive follow-up colonoscopy. Additional studies This study was supported by the National Cancer Institute, NIH (an American Recovery and Reinvestment Act supplemental award to the with larger sample sizes might provide clarification on the Systems of Support to Increase Colorectal Cancer Screening and Follow-up long-term implications of receiving an FOBT (þ)result. Trial—R01CA121125-03S1) grant award. The costs of publication of this article were defrayed in part by the Disclosure of Potential Conflicts of Interest payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate No potential conflicts of interest were disclosed. this fact.

Disclaimer The content is the sole responsibility of the authors and does not Received July 17, 2013; revised October 26, 2013; accepted October 28, represent the official views of the NIH. 2013; published OnlineFirst November 12, 2013.

References 1. Hellsten C, Sjostrom K, Lindqvist P. A 2-year follow-up study of anxiety 12. Zheng YF, Saito T, Takahashi M, Ishibashi T, Kai I. Factors associated and depression in women referred for colposcopy after an abnormal with intentions to adhere to colorectal cancer screening follow-up cervical smear. BJOG 2008;115:212–18. exams. BMC Public Health 2006;6:272. 2. Katz DA, Jarrard DF, McHorney C, Hillis SL, Wiebe DA, Fryback DG. 13. O'Donnell S, Goldstein B, Dimatteo MR, Fox SA, John CR, Obrzut JE. Health perceptions in patients who undergo screening and workup for Adherence to mammography and colorectal cancer screening in prostate cancer. Urology 2007;69:215–20. women 50–80 years of age: the role of psychological distress. Womens 3. Gray NM, Sharp L, Cotton SC, Masson LF, Little J, Walker LG, et al. Health Issues 2010;20:343–9. Psychological effects of a low-grade abnormal cervical smear 14. Trask PC, Paterson AG, Wang C, Hayasaka S, Milliron KJ, Blumberg test result: anxiety and associated factors. Br J Cancer 2006;94: LR, et al. Cancer-specific worry interference in women attending a 1253–62. breast and ovarian cancer risk evaluation program: impact on emo- 4. McNaughton-Collins M, Fowler FJJr, Caubet JF, Bates DW, Lee JM, tional distress and health functioning. Psychooncology 2001;10: Hauser A, et al. Psychological effects of a suspicious prostate cancer 349–60. screening test followed by a benign biopsy result. Am J Med 2004; 15. Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State- 117:719–25. Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists 5. Lampic C, Thurfjell E, Bergh J, Sjod€ en PO. Short-and long-term anxiety Press;1970. and depression in women recalled after breast cancer screening. Eur J 16. Lazarus RS, Folkman S. Stress, appraisal and coping. New York: Cancer 2001;37:463–9. Springer and Publishing Company;1984. 6. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of 17. Lynch BM, Steginga SK, Hawkes AL, Pakenham KI, Dunn J. Describing false positive mammograms. Ann Intern Med 2007;146:502–10. and predicting psychological distress after colorectal cancer. Cancer 7. Brasso K, Ladelund S, Frederiksen BL, Jørgensen T. Psychological 2008;112:1363–70. distress following fecal occult blood test in colorectal cancer 18. Taylor SE, Kemeny ME, Aspinwall LG, Schneider SG, Rodriguez R, screening – a population-based study. Scand J Gastroenterol Herbert M. Optimism, coping, psychological distress, and high-risk 2010;45:1211–6. sexual behavior among men at risk for acquired immunodeficiency 8. Parker MA, Robinson MH, Scholefield JH, Hardcastle JD. Psychiatric syndrome – AIDS. J Pers Soc Psychol 1992;63:460–73. morbidity and screening for colorectal cancer. J Med Screen 2002;9: 19. Suls J, Fletcher B. The relative efficacy of avoidant and nonavoidance 7–10. coping strategies: meta-analysis. Health Psychol 1985;4:249–88. 9. Mant D, Fitzpatrick R, Hogg A, Fuller A, Farmer A, Verne J, et al. 20. Carver CS, Pozo C, Harris SD, Noriega V, Scheier MF, Robinson DS, Experiences of patients with false positive results from colorectal et al. How coping mediates the effect of optimism on distress: a cancer screening. Br J Gen Pract 1990;40:423–5. study of women with early stage breast cancer. J Pers Soc Psychol 10. Aro AR, Pilvikki Absetz S, van Elderen TM, van der Ploeg E, van der 1993;65:375–90. Kamp LJ. False-positive findings in mammography screening induces 21. Dracup K, Westlake C, Erickson VS, Moser DK, Caldwell ML, Hamilton short-term distress – breast cancer-specific concern prevails longer. MA. Perceived control reduces emotional stress in patients with heart Eur J Cancer 2000;36:1089–97. failure. J Heart Lung Transplant 2003;22:90–3. 11. Lipkus IM, Klein WM, Rimer BK. Communicating breast cancer risks to 22. Cohen M. First-degree relatives of breast-cancer patients: cognitive women using different formats. Cancer Epidemiol Biomarkers Prev perceptions, coping, and adherence to breast self-examination. Behav 2001;10:895–8. Med 2002;28:15–22.

www.aacrjournals.org Cancer Epidemiol Biomarkers Prev; 23(1) January 2014 159

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research. Published OnlineFirst November 12, 2013; DOI: 10.1158/1055-9965.EPI-13-0722

Psychological Distress after a Positive Fecal Occult Blood Test Result among Members of an Integrated Healthcare Delivery System

Sharon S. Laing, Andy Bogart, Jessica Chubak, et al.

Cancer Epidemiol Biomarkers Prev 2014;23:154-159. Published OnlineFirst November 12, 2013.

Updated version Access the most recent version of this article at: doi:10.1158/1055-9965.EPI-13-0722

Cited articles This article cites 20 articles, 2 of which you can access for free at: http://cebp.aacrjournals.org/content/23/1/154.full#ref-list-1

Citing articles This article has been cited by 3 HighWire-hosted articles. Access the articles at: http://cebp.aacrjournals.org/content/23/1/154.full#related-urls

E-mail alerts Sign up to receive free email-alerts related to this article or journal.

Reprints and To order reprints of this article or to subscribe to the journal, contact the AACR Publications Department Subscriptions at [email protected].

Permissions To request permission to re-use all or part of this article, use this link http://cebp.aacrjournals.org/content/23/1/154. Click on "Request Permissions" which will take you to the Copyright Clearance Center's (CCC) Rightslink site.

Downloaded from cebp.aacrjournals.org on September 29, 2021. © 2014 American Association for Cancer Research.